menu
    • menu

    Company profile for SAFC

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SAFC is the custom manufacturing and services business unit of Sigma-Aldrich Corporation. The Company is recognized as a top 10 global specialty chemicals and biologics supplier. As a trusted manufacturer for the life science and high technology industries, SAFC works closely with customers to resolve development challenges and accelerate the product pipeline utilizing its global “Centers of Excellence” and dedicated manuf...
    SAFC is the custom manufacturing and services business unit of Sigma-Aldrich Corporation. The Company is recognized as a top 10 global specialty chemicals and biologics supplier. As a trusted manufacturer for the life science and high technology industries, SAFC works closely with customers to resolve development challenges and accelerate the product pipeline utilizing its global “Centers of Excellence” and dedicated manufacturing facilities. SAFC is committed to being the preferred global supplier of raw materials for development and manufacturing within the life science and high technology industries. We strive to bring our customers relevant solutions and quality products that exceed expectations and grow their business through our customer intimate approach. SAFC endeavors to be at the forefront of helping customers make products that matter and make a difference.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SAFCUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3050 Spruce Street, St. Louis, MO 63103
    Telephone
    Telephone
    +1 314 289 8454
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sigma-aldrich.com/safc.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI South East Asia

    Not Confirmed

    envelop Contact Supplier

    CPhI South East Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 1235

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaProviding RSMs & API to Global Pharma CompaniesProviding RSMs & API to Global Pharma Companies

    Providing RSMs & API to Global Pharma Companies
    Providing RSMs & API to Global Pharma Companies

    reelProviding RSMs & API to Global Pharma Companies

    This PharmaReel showcases Allsino Pharmaceutical, a company that provides GMP-certified RSMs and APIs to global pharma companies, specializing in peptides, oligonucleotides, and small molecule CDMO services. Allsino has a presence in the US, EU, China and Japan.

    Impressions: 1215

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    The pharmaceutical industry has witnessed a wave of mergers, acquisitions, and strategic partnerships so far in the first half (H1) of 2025, with deal values exceeding US$ 170 billion.PharmaCompass’ data shows oncology alone accounted for nearly US$ 47 billion in deal value, followed by US$ 18 billion each in immunology and psychiatry, US$ 17 billion in nutrition/weight loss and US$ 7 billion in neurology.Pharma majors such as Johnson & Johnson and Bristol Myers Squibb led with two deals worth over US$ 10 billion each. Sanofi executed a series of deals in the immunology and neuro-inflammation space. And Eli Lilly stood out for its aggressive dealmaking, which spanned oncology, pain, RNA therapies, and AI-driven oligonucleotides. In all, it signed seven deals worth over US$ 1 billion each. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available)H1 records several mega deals as J&J buys Intra-Cellular, BMS ties up with BioNTech, Sanofi acquires BlueprintJohnson & Johnson dominated headlines with its US$ 14.6 billion acquisition of Intra-Cellular Therapies in January 2025. This marks the largest biopharma deal since Novo Nordisk’s US$ 16.5 billion acquisition of Catalent in February 2024. This acquisition positions J&J as a formidable player in the neuroscience space. Bristol Myers Squibb entered into a US$ 11.1 billion partnership with BioNTech. The deal structure — US$ 3.5 billion in unconditional payments and up to US$ 7.6 billion in milestone payments — demonstrates BMS’ confidence in BNT327, a next-generation bispecific antibody in phase 3 trials for treating extensive stage small cell lung cancer and non-small cell lung cancer.Sanofi acquired Blueprint Medicines for US$ 9.5 billion in order to enhance its rare disease portfolio. The French drugmaker is also creating a comprehensive immunology portfolio. The company signed a US$ 1.9 billion deal for Dren Bio’s DR-0201 bispecific antibody for autoimmune diseases. Sanofi also acquired Vigil Neuroscience for US$ 470 million for its phase 2-ready Alzheimer’s disease candidate. Additionally, the drugmaker secured a US$ 1.84 billion global license agreement with Earendil Labs for two next-generation bispecific antibodies.Pfizer’s US$ 6.05 billion partnership with 3SBio provides it global licensing rights (excluding China) for SSGJ-707, a bispecific antibody currently undergoing multiple clinical trials in China for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Obesity gold rush sees Roche, AbbVie, Sciwind ink deals; Novo pledges over US$ 5 bn across three dealsThe obesity therapeutics market has triggered intense competition among pharmaceutical giants. Roche’s US$ 5.3 billion partnership with Zealand Pharma is focused on petrelintide, an amylin analog designed to preserve lean mass better than existing GLP-1-based treatments. The collaboration combines petrelintide with Roche’s dual GLP-1/GIP receptor agonist CT-388, creating a differentiated obesity treatment.Market leader Novo Nordisk has promised over US$ 5 billion across three major obesity deals in 2025. The US$ 2.2 billion Septerna collaboration targets oral small molecule medicines for obesity and cardiometabolic diseases.Novo signed a separate US$ 2 billion agreement with China’s United Biotechnology for UBT251, a triple agonist for GLP-1, GIP, and glucagon receptors in phase 2 clinical development for obesity, type 2 diabetes, and other diseases. The company’s third major deal, a US$ 1 billion partnership with Lexicon Pharmaceuticals, provides it access to LX9851, a molecule in preclinical development for obesity and associated metabolic disorders.Sciwind Biosciences secured a US$ 2.5 billion global licensing and collaboration agreement with Verdiva Bio Limited for the global development and commercialization of a portfolio of metabolic diseases therapies. AbbVie entered the amylin arena through its US$ 2.2 billion Gubra partnership for GUB014295, a candidate in phase 1 trials for treating obesity. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Molecular glue degraders draw investments; Lilly signs seven deals over US$ 1 billion eachMolecular glue degraders have emerged as a transformative therapeutic modality, attracting significant investment across multiple partnerships. AbbVie’s US$ 1.64 billion collaboration with Neomorph leverages the biotech’s leading molecular glue discovery platform for oncology and immunology applications.Genentech’s potential US$ 2.1 billion partnership with Orionis Biosciences focuses on small-molecule monovalent glue medicines for novel and challenging oncology targets. This is the second partnership between the two companies, following their initial 2023 collaboration.Eli Lilly has collaborated with Magnet Biomedicine, utilizing Magnet’s TrueGlue discovery platform for oncology applications. The deal could be worth up to US$ 1.3 billion.Eli Lilly has emerged as one of 2025’s most active dealmakers, with approximately seven deals exceeding US$ 1 billion each. The company’s US$ 2.5 billion Scorpion Therapeutics acquisition provides access to STX-478, an experimental oral therapy in early-stage trials for breast cancer and advanced solid tumors, potentially addressing 30 to 40 percent of hormone-positive breast cancer patients.On June 17, Lilly announced the acquisition of gene-editing startup Verve Therapeutics for US$ 1.3 billion. Lilly’s US$ 1 billion SiteOne acquisition announced in May brings STC-004, a phase 2-ready non-opioid chronic pain treatment to its pipeline. Other partnerships announced by Lilly include a US$ 1.4 billion capsid licensing deal with Sangamo for central nervous system disease genomic medicines and a US$ 1.3 billion collaboration with South Korean company Rznomics for RNA-based hearing loss treatments. Lilly has also strengthened its oligonucleotide pipeline through a potential US$ 1 billion collaboration with Creyon Bio for AI-designed oligonucleotide therapies targeting RNA. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Merck KGaA acquires SpringWorks for US$ 3.9 bn; Novartis buys out Anthos for US$ 3.1 bnAstraZeneca signed a US$ 5.3 billion AI-led research agreement with China’s CSPC Pharmaceuticals Group to advance the discovery of novel oral candidates for immunological diseases. Merck KGaA acquired SpringWorks for US$ 3.9 billion in April, which gave it access to two FDA-approved therapies — Ogsiveo (nirogacestat), the first and only approved therapy for adult patients with progressing desmoid tumors requiring systemic treatment, and Gomekli (mirdametinib), the first and only FDA-approved therapy for adults and children with neurofibromatosis type 1-associated plexiform neurofibromas.Novartis’ US$ 3.1 billion Anthos Therapeutics acquisition centered around abelacimab, a potential first-in-class monoclonal antibody currently in three phase 3 studies for stroke and systemic embolism prevention in atrial fibrillation patients.GSK’s US$ 2 billion acquisition of Boston Pharmaceuticals’ efimosfermin targets steatotic liver disease (fatty liver disease). The medicine is also in clinical development for MASH treatment. GSK’s second major deal involved the US$ 1.15 billion acquisition of US biotech IDRx, strengthening its gastrointestinal cancer portfolio.The pharma industry also drew some private equity interest as Bain Capital acquired Japan’s Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group for US$ 3.3 billion. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Our viewDespite an uncertain geopolitical environment, the year has seen a surge in M&As and dealmaking in the first half of 2025. However, a sizable chunk of the acquisitions were bolt-on transactions, indicating that companies are not ready to take on risks, and are buying out smaller players who strategically fit into their operations. Going forward, there are indications that M&A activity will stay strong throughout 2025. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2783

    https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025

    #PharmaFlow by PHARMACOMPASS
    19 Jun 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck unveils EU plant cuts and consolidation plan citing Sigma's US strategy
    Merck unveils EU plant cuts and consolidation plan citing Sigma's US strategy

    14 Jul 2017

    // G. MacDonald IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Processing/German-Merck-announces-EU-plant-cuts-and-consolidation-plan

    G. MacDonald IN PHARMATECHNOLOGIST
    14 Jul 2017
    Share Share
    EC says Merck and Sigma-Aldrich broke M&A procedures and could face $170m fine
    EC says Merck and Sigma-Aldrich broke M&A procedures and could face $170m fine

    07 Jul 2017

    // G. MacDonald IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Processing/EC-says-Merck-and-Sigma-Aldrich-broke-M-A-procedures

    G. MacDonald IN PHARMATECHNOLOGIST
    07 Jul 2017
    Share Share
    Improving solubility: MilliporeSigma opens dedicated meglumine site
    Improving solubility: MilliporeSigma opens dedicated meglumine site

    19 Jan 2017

    // Dan Stanton IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Ingredients/Improving-solubility-MilliporeSigma-opens-dedicated-meglumine-site

    Dan Stanton IN PHARMATECHNOLOGIST
    19 Jan 2017
    Share Share
    MilliporeSigma Expands Distribution Agreement with Roche in Canada
    MilliporeSigma Expands Distribution Agreement with Roche in Canada

    01 Dec 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/milliporesigma-expands-distribution-agreement-with-roche-in-canada-300367603.html

    PR NEWSWIRE
    01 Dec 2016
    Share Share
    Honeywell Launces New Research Chemicals Business
    Honeywell Launces New Research Chemicals Business

    29 Nov 2016

    // DRUG DEVELOPMENT

    http://www.drug-dev.com/Main/Current-News/Honeywell-Launces-New-Research-Chemicals-Business-1770.aspx

    DRUG DEVELOPMENT
    29 Nov 2016
    Share Share
    Merck's pharma unit faces tougher 2017 as fertility boost recedes
    Merck's pharma unit faces tougher 2017 as fertility boost recedes

    17 Nov 2016

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/mercks_pharma_unit_faces_tougher_2017_as_fertility_boost_recedes_1176998

    Phil Taylor PMLIVE
    17 Nov 2016
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact SAFC and get a quotation

    SAFC is a supplier offers 214 products (APIs, Excipients or Intermediates).

    Find a price of Benzyl Alcohol API bulk with DMF, CEP offered by SAFC

    Find a price of Clomipramine Hydrochloride bulk with DMF, CEP offered by SAFC

    Find a price of Dactinomycin bulk with DMF, JDMF offered by SAFC

    Find a price of Doxylamine Succinate bulk with DMF, CEP offered by SAFC

    Find a price of L-Glutamine bulk with DMF, JDMF offered by SAFC

    Find a price of Sodium Benzoate bulk with DMF, CEP offered by SAFC

    Find a price of L-Glutamine bulk with JDMF offered by SAFC

    Find a price of Sodium Bicarbonate bulk with JDMF offered by SAFC

    Find a price of Aprotinin bulk with CEP offered by SAFC

    Find a price of Bovine Serum bulk with CEP offered by SAFC

    Find a price of Brompheniramine Maleate bulk with DMF offered by SAFC

    Find a price of Catalase bulk with CEP offered by SAFC

    Find a price of Cholic Acid bulk with DMF offered by SAFC

    Find a price of Chymotrypsin bulk with CEP offered by SAFC

    Find a price of Dodecyl Maltoside bulk with DMF offered by SAFC

    Find a price of DPPC bulk with DMF offered by SAFC

    Find a price of Ethanol bulk with DMF offered by SAFC

    Find a price of Glucarpidase bulk with CEP offered by SAFC

    Find a price of Glucose bulk with JDMF offered by SAFC

    Find a price of Glycine bulk with DMF offered by SAFC

    Find a price of Hyaluronidase bulk offered by SAFC

    Find a price of L-Carnosine bulk with CEP offered by SAFC

    Find a price of L-Glutamine bulk with DMF offered by SAFC

    Find a price of L-Tyrosine API bulk with JDMF offered by SAFC

    Find a price of Levothyroxine Sodium bulk with DMF offered by SAFC

    Find a price of Lysine Hydrochloride bulk with DMF offered by SAFC

    Find a price of Maytansinoid DM1 bulk with DMF offered by SAFC

    Find a price of Mebrofenin bulk with DMF offered by SAFC

    Find a price of Nortriptyline bulk with DMF offered by SAFC

    Find a price of Palmitic Acid Chloride bulk with DMF offered by SAFC

    Find a price of Sodium Metaarsenite bulk with DMF offered by SAFC

    Find a price of Sulfo-Smcc bulk with DMF offered by SAFC

    Find a price of Tripalmitin bulk with DMF offered by SAFC

    Find a price of Trypan Blue bulk with DMF offered by SAFC

    Find a price of Urea API bulk with DMF offered by SAFC

    Find a price of Vitamin D bulk with DMF offered by SAFC

    Find a price of EX-CELL PF CHO MEDIUM (MODIFIED) DEFICIENT bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60259, CHOKO STOCK CULTURE MEDIUM POWDER bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60274 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60256 CHOKO FMA POWDER bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60229 bulk with DMF offered by SAFC

    Find a price of MAYTANSINOL-N-METHYL-L-ALANYL ESTER bulk with DMF offered by SAFC

    Find a price of EX-CELL PF CHO PART A (MODIFIED) bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM 14366C bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60257, CHOKO FMB POWDER bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60273 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR40118 bulk with DMF offered by SAFC

    Find a price of EX-CELL(TM) 325 PF CHO, SERUM-FREE MEDIUM, PROTEIN FREE bulk with DMF offered by SAFC

    Find a price of QBSF60 MEDIUM PRODUCT NO. 62520 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60275 bulk with DMF offered by SAFC

    Find a price of EX-CELL CD HEK293 VIRAL VECTOR MEDIUM bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60258 CHOKO PRODUCTION MEDIUM POWDER bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60219 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60234 bulk with DMF offered by SAFC

    Find a price of Medium/Medium additives・EX-CELL(R) Basal Medium bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · EX-CELL 325 PF CHO Serum-Fr ee Medium for CHO Cells bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive / IMF8 bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL (TM) CD Hydrolysate Fusion Animal Coordinate Free, Chemically Defined bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives/GM BI 221 Feed Powder bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive ・ IMF9-2X bulk with JDMF offered by SAFC

    Find a price of Culture medium/Culture additives: EX-CELL® Advanced CHO Fed-batch Medium bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives/GM BI 215 Medium Powder bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL Advanced CHO Feed 1 (without glucose) bulk with JDMF offered by SAFC

    Find a price of Medium/Medium Additives・Ex-CELL EBx GRO-I Serum-Free Medium for Embryonic Stem Cells bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL ACF CHO Medium bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives ・ CHOKO FMB Powerer bulk with JDMF offered by SAFC

    Find a price of Culture medium/Culture additive TE1 bulk with JDMF offered by SAFC

    Find a price of Culture medium/Culture additives: IMF8 bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive ・ CHOKO Production Medium Powerer bulk with JDMF offered by SAFC

    Find a price of Culture medium/Culture additives: IMB9 bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives ・ CHOKO Stock Culture Medium Powerer bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive R17 bulk with JDMF offered by SAFC

    Find a price of Culture medium/Culture additives・C8862: EX-CELL CHO DHFR- Medium bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive R7A-1 bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · Sigma EX-CELL PF CHO Mediu m (Modified) bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive ・R36 Low B12 bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · Ex-CELL EBx GRO-Ⅰ Serum-Fre e Medium for Embryonic Stem Cells bulk with JDMF offered by SAFC

    Find a price of Media/Media Additives GS2-N Low B12 No Hydrocort bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives・40X Insect Cell Feed bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · EX-CELL EBx PRO-Ⅰ Serum-Fre e Media bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives・EX-CELL(R) Feed Medium bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive / IMB9 bulk with JDMF offered by SAFC

    Find a price of Medium / media supplements · EX-CELL (TM) 325 PF CHO Protei n-Free Medium (Modified) bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive ・ TE1 bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive / IMB8 bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives/GM BI 203 Medium Powder bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL Advanced (TM) Modified bulk with JDMF offered by SAFC

    Find a price of Media/Medium Additives・EX-CELL EBx PRO-I Serum-Free Media bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives ・ CHO Kit 2 Iron Chelator Solution bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives ・ CHOKO FMA Powerer bulk with JDMF offered by SAFC

    Find a price of Culture medium/Culture additives EX-CELL(TM) 302 (Modified 68272C) Animal Component Free Media without Sodium Bicarbonate bulk with JDMF offered by SAFC

    Find a price of Culture medium/Culture additives: IMB8 bulk with JDMF offered by SAFC

    Find a price of Media/Media Additives ・Trace Element E 1000X Solution bulk with JDMF offered by SAFC

    Find a price of Culture medium/culture medium additives PER2 bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive ・R34B Medium bulk with JDMF offered by SAFC

    Find a price of Deoxyribonuclease I, Desoxyribonuclease I Crude Lyophilized Powder, Product Number D0876/DN25 and Desoxyribonuclease I Type II, Product Number D4527 bulk with CEP offered by SAFC

    Find a price of Medium/medium additive ・Trace Element B Solution B (1000X) bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive EX-CELL (R) 293 Serum-Free Medium for HEK 293 Cells bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · C8862: EX-CELL CHO DHFR\n- Medium bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive ・F48 Low B12 no HC bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · Fatty Acid Supplement bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · EX-CELL EBx GRO-Ⅰ Serum-Fre e Media bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-SuppAA-1 bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · StemlineⅡ Hematopoietic Stem C ell Expansion Medium bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive / PER2 bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL Advanced CHO Feed 1 bulk with JDMF offered by SAFC

    Find a price of Medium/Medium Additives・EX-CELL EBx PRO-I Serum-Free Medium for Embryonic Stem Cells bulk with JDMF offered by SAFC

    Find a price of Culture medium/Culture additives・EX-CELL EBx GRO-I Serum-Free Media bulk with JDMF offered by SAFC

    Find a price of Culture medium/culture medium additive SupAA-1 bulk with JDMF offered by SAFC

    Find a price of Culture medium/culture medium additives・EX-CELL Advanced CHO Feed 1 bulk with JDMF offered by SAFC

    Find a price of Culture medium/Culture additives: IMF9-2X bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · Sigma EX-CELL 302 Serum-Fr ee Medium for CHO Cells bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · EX-CELL EBx PRO-Ⅰ Serum-Fre e Medium for Embryonic Stem Cells bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · CHO Feed Bioreactor Supplement bulk with JDMF offered by SAFC

    Find a price of 3-5-Diiodothyropropionic Acid bulk offered by SAFC

    Find a price of 3-Amino-3-3-Chlorophenyl-Propanoic Acid bulk offered by SAFC

    Find a price of Ammonium Tetrathiomolybdate bulk offered by SAFC

    Find a price of Armodafinil bulk offered by SAFC

    Find a price of Bovine Insulin bulk offered by SAFC

    Find a price of Bovine Serum bulk offered by SAFC

    Find a price of Calcipotriol bulk offered by SAFC

    Find a price of Calcitriol bulk offered by SAFC

    Find a price of Camptothecine bulk offered by SAFC

    Find a price of Carbamazepine bulk offered by SAFC

    Find a price of Cetyl Alcohol API bulk offered by SAFC

    Find a price of Cholesterol-3,4-13C2 bulk offered by SAFC

    Find a price of Copper bulk offered by SAFC

    Find a price of Cortisol-9,11,12,12-D4 bulk offered by SAFC

    Find a price of Dextrans bulk offered by SAFC

    Find a price of Fenbendazole bulk offered by SAFC

    Find a price of Galactomannan bulk offered by SAFC

    Find a price of Gentisic Acid bulk offered by SAFC

    Find a price of GUANIDINE HYDROCHLORIDE API bulk offered by SAFC

    Find a price of Halobetasol bulk offered by SAFC

    Find a price of Halofuginone Lactate bulk offered by SAFC

    Find a price of Hexadimethrine Bromide bulk offered by SAFC

    Find a price of Homotaurine bulk offered by SAFC

    Find a price of Hydroxydopamine Hydrobromide bulk offered by SAFC

    Find a price of Iron bulk offered by SAFC

    Find a price of Isobutylmethylxanthine bulk offered by SAFC

    Find a price of Isobutyramide bulk offered by SAFC

    Find a price of Isosulfan Blue bulk offered by SAFC

    Find a price of L-Carnosine bulk offered by SAFC

    Find a price of L-Glutamine bulk offered by SAFC

    Find a price of Mafodotin [Usan] bulk offered by SAFC

    Find a price of Mebrofenin bulk offered by SAFC

    Find a price of Mechlorethamine bulk offered by SAFC

    Find a price of Methacetin-13C bulk offered by SAFC

    Find a price of Methyl Tert-Butyl Ether bulk offered by SAFC

    Find a price of Methylformamide bulk offered by SAFC

    Find a price of Pefcalcitol bulk offered by SAFC

    Find a price of Penicillamine bulk offered by SAFC

    Find a price of Pentamidine Isethionate bulk offered by SAFC

    Find a price of Percorten bulk offered by SAFC

    Find a price of Polygalacturonic Acid bulk offered by SAFC

    Find a price of Promethazine Hydrochloride bulk offered by SAFC

    Find a price of Putrescine Hydrochloride bulk offered by SAFC

    Find a price of Rhodamine 123 bulk offered by SAFC

    Find a price of Sodium Bicarbonate bulk offered by SAFC

    Find a price of Sodium Butyrate bulk offered by SAFC

    Find a price of Sodium Metaarsenite bulk offered by SAFC

    Find a price of Sodium Octanoate-1-13C bulk offered by SAFC

    Find a price of Squalene API bulk offered by SAFC

    Find a price of Thrombin bulk offered by SAFC

    Find a price of Trypan Blue bulk offered by SAFC

    Find a price of Vitamin D3 bulk offered by SAFC

    Find a price of STEMLINE(TM) II HEMATOPOIETIC STEM CELL EXPANSION MEDIUM bulk offered by SAFC

    Find a price of 9-AMINO-1,2,3,4,-TETRAHYDROCRIDINE HCL. (THA) bulk offered by SAFC

    Find a price of CHO MEDIUM-ANIMAL COMPONENT-FREE bulk offered by SAFC

    Find a price of PHOSPHATE BUFFERED SALINE (PRODUCT 62137) bulk offered by SAFC

    Find a price of SGD-1006 (SG6) bulk offered by SAFC

    Find a price of EX-CELL 400 bulk offered by SAFC

    Find a price of HEMOCYANIN FROM KEYHOLE LIMPET bulk offered by SAFC

    Find a price of EX-CELL 302 MEDIUM (MODIFIED) CAT. #62630 bulk offered by SAFC

    Find a price of STEMLINE NEURAL STEM CELL EXPANSION MEDIUM bulk offered by SAFC

    Find a price of EX-CELL PF CHO MEDIUM (MODIFIED) CATALOG NO. 67480 bulk offered by SAFC

    Find a price of EX-CELL PF CHO MEDUIM (MODIFIED), CATALOG NO. 62625 bulk offered by SAFC

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN WISCONSIN. bulk offered by SAFC

    Find a price of EX-CELL PF CHO MEDIUM (MODIFIED) DEFINED SERUM-FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELL PF CHO bulk offered by SAFC

    Find a price of DMS-12 (100X) CONCENTRATE bulk offered by SAFC

    Find a price of Q1196-9 bulk offered by SAFC

    Find a price of EX-CELL(TM) 302, CHO, SERUM-FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELLr ANTIFOAM GAMMA IRRADIATED BY SER-TAINr PROCESS bulk offered by SAFC

    Find a price of EX-CELL (TM) VPRO bulk offered by SAFC

    Find a price of 62180 bulk offered by SAFC

    Find a price of EX-CELL 325 PF CHO (MODIFIED) PRODUCT NO. 63131 bulk offered by SAFC

    Find a price of EX-CELL 301 bulk offered by SAFC

    Find a price of STEMLINE™ MESENCHYMAL STEM CELL EXPANSION MEDIUM bulk offered by SAFC

    Find a price of ROSE BENGAL, DISODIUM SALT, SIGMA-ALDRICH CHEMICAL CO. PRODUCT NUMBER W184-3 bulk offered by SAFC

    Find a price of EX-CELL 302 MEDIUM (GS MODIFIED), CATALOG NO. 62639 bulk offered by SAFC

    Find a price of SERUM-FREE MEDIA SUPPLEMENT PART A (100 X) bulk offered by SAFC

    Find a price of 2-METHOXYESTRA-3,17 B-DIOL bulk offered by SAFC

    Find a price of ISCOVE'S MODIFIED DULBECCO'S MEDIUM (IMDM) bulk offered by SAFC

    Find a price of EX-CELL PF CHO MEDIUM(MODIFIED) bulk offered by SAFC

    Find a price of EX-CELL 301 COMPLETE MEDIUM (MODIFIED) bulk offered by SAFC

    Find a price of BIOTAIN-MPS TM CONCENTRATE (100X) bulk offered by SAFC

    Find a price of EX-CELL(TM) 302, CHO, SERUM-FREE MEDIUM(MODIFIED) bulk offered by SAFC

    Find a price of 1(2PHENYLETHYL)4(N(2PYRAZYL)2(FUROYLAMIDO)PIPERIDINE HCl bulk offered by SAFC

    Find a price of CHO ANIMAL-FREE MEDIUM MODIFICATION 21 bulk offered by SAFC

    Find a price of EX-CELL CD HYDROLYSATE FUSION, ANIMAL COMPONENT FREE, CHEMICALLY-DEFINED LIQUID MEDIA, (PRODUCT NO. 14700C), DRY POWDER MEDIA (PRODUCT NO. 24700C) bulk offered by SAFC

    Find a price of 67210 bulk offered by SAFC

    Find a price of STEMLINE(TM) DENDRITIC CELL MATURATION MEDIUM bulk offered by SAFC

    Find a price of EX-CELL(TM) 325 PF CHO PROTEIN-FREE MEDIUM (MODIFIED) bulk offered by SAFC

    Find a price of PF-11 bulk offered by SAFC

    Find a price of CHO MEDIUM MODIFICATION 21 bulk offered by SAFC

    Find a price of STEMMAX(TM), PRODUCT NO. 62647 bulk offered by SAFC

    Find a price of EX-CELL 610 HSF HYBRIDOMA, SERUM-FREE MEDUIM. CATALOG NO. 14610 bulk offered by SAFC

    Find a price of EX-CELL (TM) 293 MEDIUM bulk offered by SAFC

    Find a price of EX-CELL 325 PF CHO PROTEIN FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELL(TM) 302, MEDIUM, SERUM-FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELL 525 FOR PER C6 CELLS, DEFINED SERUM FREE MEDIUM bulk offered by SAFC

    Find a price of PEG TELOMER B bulk offered by SAFC

    Find a price of 93% DME (HG)/5% NCTC (CAT. NO. 52-589) bulk offered by SAFC

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search